Recent Finacing
Recent Raise
HemaQuest is a Seattle-based clinical-stage biotech developing orally administered small-molecule therapeutics—HQK-1001 (fetal hemoglobin inducer) and HQK-1004—for sickle cell disease, beta thalassemia, and EBV-associated hematologic cancers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors